Institute for Global Health (IGH)
About the IGH
The IGH, established in 2015 at the University of Maryland School of Medicine, is dedicated to improving global health by conducting innovative, world-leading research in Baltimore and around the world.
A Global Foot Print:
Current Research and Development
(mouse over red markers to learn about each of our global research projects)
Within the IGH is the Center for Vaccine Development (CVD), which is led by Kathleen Neuzil, MD, MPH, and the Division of Malaria Research, which under the leadership of Miriam Laufer, M.D.
For over 40 years, CVD has worked domestically and internationally to develop, test, and deploy vaccines to aid the world’s underserved populations.The Division of Malaria Research performs the crucial work needed to support global malaria eradication. That work includes developing and deploying innovative tools for improved malaria treatment, prevention and surveillance. The IGH is an instrumental partner in international initiatives to eliminate malaria in Africa and other parts of the world.
With more than 30 faculty physicians and scientists, the IGH collaborates with other School of Medicine institutes, centers, departments and programs, as well as other schools on campus, and other entities within the University System of Maryland.